News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
177,202 Results
Type
Article (12617)
Company Profile (97)
Press Release (164484)
Multimedia
Podcasts (53)
Webinars (8)
Section
Business (53569)
Career Advice (974)
Deals (8875)
Drug Delivery (63)
Drug Development (20382)
Employer Resources (62)
FDA (3336)
Job Trends (4804)
News (85145)
Policy (5921)
Tag
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (836)
Accelerated approval (9)
Adcomms (5)
Allergies (35)
Alliances (13877)
ALS (48)
Alzheimer's disease (505)
Antibody-drug conjugate (ADC) (179)
Approvals (3384)
Artificial intelligence (259)
Autoimmune disease (69)
Automation (22)
Bankruptcy (69)
Best Places to Work (3445)
BIOSECURE Act (7)
Biosimilars (48)
Biotechnology (72)
Bladder cancer (49)
Brain cancer (26)
Breast cancer (208)
Cancer (1981)
Cardiovascular disease (122)
Career advice (823)
Career pathing (22)
CAR-T (152)
CDC (16)
Cell therapy (380)
Cervical cancer (12)
Clinical research (17526)
Collaboration (841)
Company closure (2)
Compensation (264)
Complete response letters (18)
COVID-19 (945)
CRISPR (50)
C-suite (508)
Cystic fibrosis (59)
Data (2336)
Decentralized trials (1)
Denatured (12)
Depression (44)
Diabetes (173)
Diagnostics (2208)
Digital health (13)
Diversity (5)
Diversity, equity & inclusion (12)
Drug discovery (127)
Drug pricing (90)
Drug shortages (11)
Duchenne muscular dystrophy (91)
Earnings (19642)
Editorial (29)
Employer branding (7)
Employer resources (56)
Events (23651)
Executive appointments (520)
FDA (4354)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (10)
Funding (758)
Gene editing (115)
Generative AI (23)
Gene therapy (274)
GLP-1 (392)
Government (1056)
Grass and pollen (1)
Guidances (145)
Healthcare (5198)
HIV (20)
Huntington's disease (23)
IgA nephropathy (43)
Immunology and inflammation (120)
Immuno-oncology (35)
Indications (31)
Infectious disease (1024)
Inflammatory bowel disease (75)
Inflation Reduction Act (13)
Influenza (34)
Intellectual property (80)
Interviews (224)
IPO (4088)
IRA (24)
Job creations (1455)
Job search strategy (638)
JPM (35)
Kidney cancer (11)
Labor market (53)
Layoffs (240)
Leadership (24)
Legal (923)
Liver cancer (20)
Longevity (5)
Lung cancer (257)
Lymphoma (170)
Machine learning (29)
Management (24)
Manufacturing (391)
MASH (61)
Medical device (3306)
Medtech (3317)
Mergers & acquisitions (5218)
Metabolic disorders (507)
Multiple sclerosis (66)
NASH (5)
Neurodegenerative disease (138)
Neuropsychiatric disorders (42)
Neuroscience (983)
Neurotech (1)
NextGen: Class of 2026 (1850)
Non-profit (1272)
Now hiring (36)
Obesity (268)
Opinion (142)
Ovarian cancer (79)
Pain (75)
Pancreatic cancer (83)
Parkinson's disease (98)
Partnered (20)
Patents (165)
Patient recruitment (193)
Peanut (14)
People (18991)
Pharmaceutical (11)
Pharmacy benefit managers (5)
Phase 1 (6618)
Phase 2 (8079)
Phase 3 (5255)
Pipeline (2177)
Policy (116)
Postmarket research (254)
Preclinical (2546)
Press Release (19)
Prostate cancer (70)
Psychedelics (18)
Radiopharmaceuticals (134)
Rare diseases (319)
Real estate (1833)
Recruiting (26)
Regulatory (5243)
Reports (25)
Research institute (755)
Resumes & cover letters (146)
Rett syndrome (10)
RNA editing (13)
RSV (14)
Schizophrenia (65)
Series A (162)
Series B (96)
Service/supplier (3)
Sickle cell disease (41)
Special edition (18)
Spinal muscular atrophy (34)
Sponsored (15)
Startups (1408)
Stomach cancer (4)
Supply chain (34)
Tariffs (54)
The Weekly (41)
Vaccines (366)
Venture capital (58)
Weight loss (173)
Women's health (23)
Worklife (11)
Date
Last 7 days (207)
Last 30 days (818)
Last 365 days (11284)
2026 (1108)
2025 (11274)
2024 (11726)
2023 (12909)
2022 (17136)
2021 (18622)
2020 (16326)
2019 (11681)
2018 (8956)
2017 (8367)
2016 (7549)
2015 (8571)
2014 (5849)
2013 (4638)
2012 (4968)
2011 (5058)
2010 (4366)
Location
Africa (269)
Alabama (21)
Alaska (2)
Arizona (56)
Arkansas (6)
Asia (10539)
Australia (1834)
California (4782)
Canada (1004)
China (463)
Colorado (130)
Connecticut (119)
Delaware (106)
Europe (24303)
Florida (476)
Georgia (89)
Hawaii (3)
Idaho (16)
Illinois (219)
India (18)
Indiana (208)
Iowa (14)
Japan (174)
Kansas (86)
Kentucky (10)
Louisiana (5)
Maine (26)
Maryland (569)
Massachusetts (2901)
Michigan (102)
Minnesota (145)
Mississippi (4)
Missouri (43)
Montana (7)
Nebraska (6)
Nevada (27)
New Hampshire (27)
New Jersey (920)
New Mexico (12)
New York (990)
North Carolina (387)
North Dakota (4)
Northern California (2495)
Ohio (150)
Oklahoma (6)
Oregon (16)
Pennsylvania (591)
Puerto Rico (5)
Rhode Island (13)
South America (333)
South Carolina (17)
Southern California (1717)
Tennessee (44)
Texas (735)
United States (14024)
Utah (78)
Vermont (1)
Virginia (68)
Washington D.C. (22)
Washington State (317)
West Virginia (2)
Wisconsin (53)
177,202 Results for "next frontier biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Frontier Medicines Announces Publication in Nature Communications Highlighting a Novel Method that Enables Next-Generation Covalent Medicines
January 5, 2026
·
3 min read
Insights
As FDA Deploys Agentic AI, Pharma Begins Testing the Next Frontier of Intelligent Automation
The agency’s sweeping rollout and staff challenge underscore rising momentum behind agentic AI: advanced, multiagent systems now fueling early pilots in medical writing, patient engagement and regulatory workflows across the industry.
December 8, 2025
·
3 min read
·
Jennifer Smith-Parker
Press Releases
LIfT BioSciences Announces CEO Transition to Drive Next Phase of Growth with Neutrophil-based Therapies
January 7, 2026
·
4 min read
Press Releases
Microbiome Therapeutics: A Universal Solution for Future Generations and the New Frontier of Medicine - Commentary by unexakorea
January 20, 2026
·
4 min read
Press Releases
Prasco Announces Strategic Collaboration with Frontier Scientific Solutions
December 3, 2025
·
2 min read
Mergers & acquisitions
6 Biotechs That Could Be Big Pharma’s Next M&A Target
Metsera showed the biopharma world that M&A is back. Who could be next?
December 17, 2025
·
8 min read
·
Annalee Armstrong
Weight loss
Novo’s Next-Gen Obesity Drug Beats Wegovy on Blood Sugar Control in Phase III
While CagriSema bested Novo Nordisk’s Wegovy on blood sugar control in a late-stage trial, the next-gen weight loss drug still has not met the pharma’s 25% weight loss goal.
February 3, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Precede Biosciences Secures $83.5M in Total Financing to Scale Next-Generation Precision Diagnostics Platform
January 12, 2026
·
3 min read
Press Releases
Ensysce Biosciences Provides Enrollment Update on Pivotal Phase 3 Trial of PF614, Its Next-Generation Opioid for Severe Acute Pain
January 29, 2026
·
4 min read
Press Releases
Insilico Medicine Launches Science MMAI Gym to Transform Frontier LLMs into Pharmaceutical-Grade Scientific Engines
January 22, 2026
·
1 min read
1 of 17,721
Next
